(VIANEWS) – REC SILICON (RECSI.OL), TELEPERFORMANCE (TEP.PA), MELHUS SPAREBANK (MELG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. REC SILICON (RECSI.OL)
165% sales growth and 44.59% return on equity
REC Silicon ASA, together with its subsidiaries, produces and sells silicon materials for the solar and electronics industries worldwide. It offers various Signature Silane gas, a pure form of silicon that produces product for fuel industries comprising specialty gases, including Dichlorosilane, Monochlorosilane, and Disilane for use in the manufacturing processes of flat panel displays, semiconductors, and solar cells; solar grade polysilicon, including NextSi used for multi crystalline and monocrystalline solar ingot and wafer production in the manufacturing of solar modules; and electronic grade polysilicon consisting of float zone-based devices are used in motor control and power conversion processes for hybrid and electric vehicles, wind energy, and high voltage transmission, 5G communications, high-speed trains, internet of things, and big data, as well as Czochralski for manufacturing of semiconductor wafers used in memory processors, optics, and micro electromechanical systems. The company was formerly known as Renewable Energy Corporation ASA and changed its name to REC Silicon ASA in October 2013. REC Silicon ASA was founded in 1996 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, REC SILICON has a trailing twelve months EPS of kr0.78.
PE Ratio
REC SILICON has a trailing twelve months price to earnings ratio of 13.53. Meaning, the purchaser of the share is investing kr13.53 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.59%.
Moving Average
REC SILICON’s value is higher than its 50-day moving average of kr10.49 and way below its 200-day moving average of kr13.63.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 48.2% and 66.7%, respectively.
Sales Growth
REC SILICON’s sales growth is 140.3% for the current quarter and 165% for the next.
Yearly Top and Bottom Value
REC SILICON’s stock is valued at kr10.55 at 22:20 EST, way below its 52-week high of kr18.48 and way above its 52-week low of kr8.50.
More news about REC SILICON.
2. TELEPERFORMANCE (TEP.PA)
30.8% sales growth and 15.23% return on equity
Teleperformance SE, together with its subsidiaries, engages in the customers consultancy services in France and internationally. The company operates in two segments, Core Services and Digital Integrated Business Services, and Specialized Services. The company offers customer relationship operations, technical support, technical assistance and customer acquisition services, management of business processes, back office and digital platform services, consulting, data analysis services, on-line interpretation, visa application management, health management services, and accounts receivable credit management services, and recruitment process outsource services. It also provides digital CX, trust and safety, artificial intelligence, video CX, metaverse, CX management, advanced analytics, business transformation consulting, technology as a service, collection service, interpretation and translation, and healthcare support services. The company serves automotive, energy and utilities, insurance, government, technology, travel and hospitality, and banking and financial services, as well as healthcare, media, retail and e-commerce, cargo, telecom, and video games industries. Teleperformance SE was incorporated in 1989 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, TELEPERFORMANCE has a trailing twelve months EPS of €10.18.
PE Ratio
TELEPERFORMANCE has a trailing twelve months price to earnings ratio of 8.85. Meaning, the purchaser of the share is investing €8.85 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.23%.
Sales Growth
TELEPERFORMANCE’s sales growth is 23.7% for the current quarter and 30.8% for the next.
Yearly Top and Bottom Value
TELEPERFORMANCE’s stock is valued at €90.08 at 22:20 EST, way under its 52-week high of €190.35 and way higher than its 52-week low of €80.76.
More news about TELEPERFORMANCE.
3. MELHUS SPAREBANK (MELG.OL)
19.6% sales growth and 9.74% return on equity
Melhus Sparebank, a savings bank, provides various banking products and services to companies, agriculture customers, and private individuals in Norway. The company offers savings accounts; construction and business loans; mortgage, and car loans; bank guarantee, overdraft, and leasing services; and credit and bank cards. It also provides various insurance products for home, cottage, household goods, contents, drone, car, boat, other vehicles, travel, animal, children, death, health, critical illness, disabled, private, commercial, agricultural, and accident; savings and pension products; payment services; and online and mobile banking services. The company operates through branch offices in central Trondheim, Heimdal, Ler, and Korsvegen. Melhus Sparebank was founded in 1840 and is headquartered in Melhus, Norway.
Earnings Per Share
As for profitability, MELHUS SPAREBANK has a trailing twelve months EPS of kr16.09.
PE Ratio
MELHUS SPAREBANK has a trailing twelve months price to earnings ratio of 9.53. Meaning, the purchaser of the share is investing kr9.53 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.74%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 3.9% and a negative 27.7%, respectively.
More news about MELHUS SPAREBANK.
4. SPBK1 NORD-NORGE (NONG.OL)
18.4% sales growth and 15.39% return on equity
SpareBank 1 Nord-Norge provides banking services in Northern Norway. It operates through Retail Market and Corporate Market segments. The company offers mortgage, car, boat, vehicle, and other loan related services. It also offers vehicle, home, travel, personal, and pet insurance services. In addition, the company provides various savings and pension related services, as well as debit and credit card services. Further, it offers accounting services, real estate brokerage, and leasing/sale-leaseback financing, internet banking, and mobile services. SpareBank 1 Nord-Norge was founded in 1836 and is headquartered in Tromsø, Norway.
Earnings Per Share
As for profitability, SPBK1 NORD-NORGE has a trailing twelve months EPS of kr11.52.
PE Ratio
SPBK1 NORD-NORGE has a trailing twelve months price to earnings ratio of 8.76. Meaning, the purchaser of the share is investing kr8.76 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.39%.
Yearly Top and Bottom Value
SPBK1 NORD-NORGE’s stock is valued at kr100.96 at 22:20 EST, under its 52-week high of kr106.20 and way above its 52-week low of kr90.00.
Sales Growth
SPBK1 NORD-NORGE’s sales growth is 17% for the current quarter and 18.4% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 15, 2024, the estimated forward annual dividend rate is 7 and the estimated forward annual dividend yield is 7.09%.
Volume
Today’s last reported volume for SPBK1 NORD-NORGE is 97977 which is 11.3% below its average volume of 110469.
More news about SPBK1 NORD-NORGE.
5. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 15.31% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 18.43. Meaning, the purchaser of the share is investing kr18.43 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.31%.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr23.40 at 22:20 EST, under its 52-week high of kr25.10 and way higher than its 52-week low of kr18.05.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the present quarter and 6.6% for the next.
More news about VISTIN PHARMA.
